Granules India Riaz Ahmed resigns as Senior Vice President & Head- Supply Chain Management
Hyderabad: Granules India, a vertically integrated Indian pharmaceutical company, has announced the resignation of Riaz Ahmed as Senior Vice President & Head- Supply Chain Management.
"Riaz Ahmed, shall cease to be the Senior Management Personnel (SMP) of the Company upon his resignation from the position of Senior Vice President & Head- Supply Chain Management with effect from the closure of business hours of February 03, 2025," the company stated in a BSE filing.
"I have decided to pursue other opportunities outside Granules India, therefore decided to resign from the services of Granules India," Ahmed said in a resignation letter.
Read also: Granules India appoints Dr Rajesh Kapoor as Global Head of Quality
Granules India had earlier reported that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), had received final approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine Dimesylate Capsules in strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg.
Read also: Granules India arm gets USFDA nod for ADHD drug Lisdexamfetamine Dimesylate
Granules India Limited, incorporated in 1991 is a vertically integrated Indian pharmaceutical company headquartered in Hyderabad. Amongst the few pharmaceutical companies in the world to be present across the manufacturing of the entire pharmaceutical value chain – from Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs), Granules products are distributed to over 300+ customers in regulated and semiregulated markets with a global presence extending to over 80+ countries with offices across India, US and UK. The Company has 10 manufacturing facilities out of which 8 are located in India and 2 are in the USA and has regulatory approvals from the US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC, and HALAL.
Read also: Granules India appoints Ramraj Rangarajulu as President, Head of Formulations Operations
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.